Organogenesis is a corporation based in Canton, MA. They profit from Apligraf, which is a synthetic skin created from harvested foreskins. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Call for increase of foreskin harvesting
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."
- ↑ 1.0 1.1 "Headquarters". Organogenesis. http://www.organogenesis.com/about_us/headquarters.html. Retrieved 2011-03-06. "The corporate headquarters and manufacturing facility are located in Canton, Massachusetts."
- ↑ "November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript". November 2011. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf. Retrieved 2011-12-20.